Treasury Chief Reeves Plans Targeted Measures on Living Costs in Forthcoming Budget

Chancellor Rachel Reeves has announced she is planning "targeted measures to address household expense pressures" in the forthcoming Budget.

During an interview with media outlets, she stated that curbing price rises is a joint task of both the government and the central bank.

The UK's inflation rate is forecast to be the highest among the G7 advanced economies this calendar year and next.

Possible Energy Cost Interventions

Sources suggest the administration could intervene to bring down utility costs, for instance by cutting the present 5% rate of value-added tax charged on energy supplies.

An additional possibility is to lower some of the policy costs currently added to household expenses.

Fiscal Limitations and Expert Expectations

The administration will receive the next report from the independent fiscal watchdog, the OBR, on the start of the week, which will show how much scope there is for such measures.

The view from most experts is that Reeves will have to announce higher taxes or spending cuts in order to meet her self-imposed fiscal targets.

Previously on Thursday, estimates indicated there was a £22bn gap for the Treasury chief to fill, which is at the lower end of expectations.

"It is a shared responsibility between the central bank and the government to continue tackling some of the drivers of inflation," Reeves informed the BBC in the US capital, at the conferences of the International Monetary Fund and World Bank.

Tax Pledges and International Issues

While a great deal of the focus has been on probable tax increases, the chancellor said the latest information from the OBR had not changed her vow to campaign commitments not to increase tax levels on income tax, VAT or social security contributions.

She attributed an "uncertain global environment" with rising geopolitical and trade concerns for the fiscal revenue measures, likely to be directed on those "wealthiest."

International Trade Tensions

Referring to concerns about the UK's commercial links with the Asian nation she said: "The UK's national security always come first."

Last week's statement by Chinese authorities to strengthen trade restrictions on rare earths and other materials that are crucial for advanced tech manufacturing led American leader Donald Trump to propose an further 100% tariff on goods from China, increasing the possibility of an full-scale commercial conflict between the two economic giants.

The American finance chief described the Chinese action "economic coercion" and "a international production power grab."

Inquired about considering the American proposal to participate in its battle with China, the Chancellor said she was "deeply worried" by China's measures and encouraged the Beijing authorities "to avoid restrictions and limit trade."

She said the decision was "bad for the global economy and creates additional challenges."

"In my view there are areas where we need to address China, but there are also important prospects to export to China's economy, including banking sector and other sectors of the economy. We've got to get that balance right."

The chancellor also confirmed she was working with G7 counterparts "regarding our own essential resources strategy, so that we are more independent."

Health Service Medicine Pricing and Investment

Reeves also recognized that the cost the National Health Service spends on pharmaceuticals could increase as a result of current negotiations with the US government and its drugs companies, in exchange for reduced taxes and capital.

A number of the world's largest pharmaceutical manufacturers have said in recent statements that they are either halting or abandoning investments in the United Kingdom, with several attributing the modest returns they are receiving.

Last month, the government science advisor said the cost the health service spends on drugs would need to go up to halt companies and pharmaceutical investment leaving the UK.

Reeves informed media: "It has been observed as a result of the payment system, that medical research, innovative medicines have not been provided in the UK in the way that they are in other European countries."

"We want to ensure that patients receiving care from the National Health Service are able to obtain the best critical treatments in the globe. And so we are examining all of that, and... aiming to secure increased investment into Britain."